Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ADAPTATE BIOTHERAPEUTICS LTD

Company number 12166787

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
14 Apr 2021 AP01 Appointment of Christine Kim Ward as a director on 6 April 2021
12 Apr 2021 TM01 Termination of appointment of Daniel Matthew Kemp as a director on 6 April 2021
12 Apr 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
22 Mar 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 27 August 2020
  • GBP 2,532.218
15 Jan 2021 SH01 Statement of capital following an allotment of shares on 27 August 2020
  • GBP 2,529.218
  • ANNOTATION Clarification a second filed SH01 was registered on 22/03/21
08 Sep 2020 CS01 Confirmation statement made on 20 August 2020 with updates
08 Sep 2020 PSC02 Notification of Takeda Pharmaceutical Company Limited as a person with significant control on 24 October 2019
08 Sep 2020 PSC02 Notification of Abingworth Llp as a person with significant control on 17 October 2019
08 Sep 2020 PSC09 Withdrawal of a person with significant control statement on 8 September 2020
13 Aug 2020 AA Accounts for a small company made up to 31 March 2020
23 Jul 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
06 Jul 2020 SH01 Statement of capital following an allotment of shares on 1 July 2020
  • GBP 2,361.582
25 Feb 2020 SH01 Statement of capital following an allotment of shares on 18 February 2020
  • GBP 1,059.618
08 Jan 2020 MR01 Registration of charge 121667870001, created on 3 January 2020
10 Dec 2019 AA01 Current accounting period shortened from 31 August 2020 to 31 March 2020
04 Nov 2019 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
04 Nov 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
28 Oct 2019 AP01 Appointment of Mr Loic Vincent as a director on 11 October 2019
28 Oct 2019 AP01 Appointment of Mr Daniel Matthew Kemp as a director on 11 October 2019
25 Oct 2019 AP01 Appointment of Dr John Gerard Shields as a director on 14 October 2019
25 Oct 2019 AP01 Appointment of Dr Peter Neville Goodfellow as a director on 11 October 2019
25 Oct 2019 AP01 Appointment of Mr Timothy John Haines as a director on 11 October 2019
24 Oct 2019 SH01 Statement of capital following an allotment of shares on 24 October 2019
  • GBP 976.477
03 Oct 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Interests discolsed to company 27/08/2019
  • RES01 ‐ Resolution of adoption of Articles of Association
21 Aug 2019 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2019-08-21
  • GBP 114.008